Euronext stock slips to start 2026 as Europe hits record highs; ENX focus turns to Feb. results
3 January 2026
1 min read

Euronext stock slips to start 2026 as Europe hits record highs; ENX focus turns to Feb. results

NEW YORK, January 3, 2026, 08:21 ET — Market closed.

Euronext (ENX.PA) shares ended Friday down 1.9% at 125.60 euros, finishing at the session low. The Paris-listed exchange operator traded between 125.60 and 129.10 on the day and carries a market value of about 12.6 billion euros; its 52-week range is 104.40 to 153.50 euros. 1

The dip came as European stocks started 2026 at record highs, lifted by gains in technology and defence shares, with the STOXX 600 up 0.7% and London’s FTSE 100 hitting 10,000 for the first time. “Investors are keen to put money into the market without the fear of record highs,” said Nick Saunders, CEO of trading platform Webull UK. 2

That divergence matters because exchange operators are a read-through on market activity. When investors trade more, exchanges tend to collect more in transaction fees, market data sales and clearing income.

Clearing is the process that sits between buyer and seller to help ensure trades settle and losses are covered if one side fails. It can be a steadier business than cash equity trading, but it still leans on overall market activity.

Euronext sits at the intersection of those currents, because its performance can track both risk appetite and volatility. Big index milestones can bring momentum flows, but they can also prompt rebalancing after strong runs.

Friday’s close at the low suggests sellers kept control into the weekend, even as the broader European tape stayed firm. Investors often use exchange stocks as a way to take a view on the health of capital markets without betting on a single sector.

The competitive set includes Deutsche Boerse and London Stock Exchange Group, which, like Euronext, have been building out recurring revenue streams in data and post-trade services to smooth out the highs and lows of trading volumes.

Rates also stayed in focus. U.S. Treasury yields rose on Friday as markets looked ahead to next week’s run of employment data for signals on growth and the path of interest rates. 3

Moves in yields can ripple into equities through discount rates and funding costs, and that can change how much investors hedge and trade. For market operators, more hedging activity can support derivatives volumes even when cash equity flows slow.

Before the next session, investors will also start to look ahead to Euronext’s full-year 2025 results, scheduled for Feb. 18, according to the company’s financial calendar. 4

Traders will look for management’s tone on the durability of trading and clearing revenues after a strong year for European equities, and for any updated view on costs and shareholder returns. Guidance watchpoints typically include whether activity in cash equities stays resilient and whether derivatives demand remains elevated.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
BYD Stock Faces Shenzhen Reopen Test After 2025 Sales Growth Hits 5-Year Low
Previous Story

BYD Stock Faces Shenzhen Reopen Test After 2025 Sales Growth Hits 5-Year Low

HKEX stock jumps 2% on AI-led Hong Kong rally as IPO buzz returns — what’s next for 0388.HK
Next Story

HKEX stock jumps 2% on AI-led Hong Kong rally as IPO buzz returns — what’s next for 0388.HK

Go toTop